Microdialysis for pharmacokinetic-pharmacodynamic studies

Pharmazie

Volumn 62, Issue 12, 2007, Pages 883-891

  Yu, W ^a   Cheng, Q ^a   Feng, J ^a   Li, Fanzhu ^a  

^a ZHEJIANG CHINESE MEDICAL UNIVERSITY   (China)

Author keywords

[No Author keywords available]

Indexed keywords

5 HYDROXY 2 (DIPROPYLAMINO)TETRALIN; 7 NITROINDAZOLE; ANTIINFECTIVE AGENT; ANTINEOPLASTIC AGENT; ARGININE; BENZATROPINE; CAFFEINE; CEFIXIME; CEFPODOXIME; CENTRAL NERVOUS SYSTEM AGENTS; CIPROFLOXACIN; DOPAMINE RECEPTOR STIMULATING AGENT; ESCITALOPRAM; FLUOROURACIL; METHOTREXATE; METHYLDOPA; METHYLPHENIDATE; METOPROLOL; MORPHINE; NORFLOXACIN; OXYCODONE; ROCURONIUM; SEROTONIN UPTAKE INHIBITOR; TEMOZOLOMIDE; UNCLASSIFIED DRUG;

AUTONOMIC NERVOUS SYSTEM; CENTRAL NERVOUS SYSTEM; DRUG APPROVAL; DRUG COST; DRUG EFFICACY; DRUG INFORMATION; DRUG SAFETY; DRUG TARGETING; EXTRACELLULAR FLUID; HUMAN; MICRODIALYSIS; NONHUMAN; OPTIMAL DRUG DOSE; PHARMACODYNAMICS; PHARMACOKINETICS; REVIEW;

ALGORITHMS; ANIMALS; ANTI-INFECTIVE AGENTS; ANTINEOPLASTIC AGENTS; AUTONOMIC AGENTS; CENTRAL NERVOUS SYSTEM AGENTS; HUMANS; MICRODIALYSIS; MODELS, STATISTICAL; PHARMACOKINETICS;

EID: 37349064097     PISSN: 00317144     EISSN: None     Source Type: Journal    
DOI: 10.1691/ph.2007.12.7049     Document Type: Review

References (87)

1. Baseski HM, Watson CJ, Cellar NA, Shackman JG, Kenedy RT (2005) Capillary liquid chromatography with MS3 for the determination of enkephalins in microdialysis samples from the striatum of anesthetized and freely moving rats. J Mass Spectrom 40: 146-153.
2. Birkenfeld AL, Boschmann M, Moro C, Adams F, Heusser K, Tank J, Diedrich A, Schroeder C, Franke G, Berlan M, Luft FC, Lafontan M, Jordan J (2006) Beta-adrenergic and atrial natriuretic peptide interactions on human cardiovascular and metabolic regulation. J Clin Endocrinol Metab 91: 5069-5075.
3. Black JW, Leff P (1983) Operational models of pharmacological agonism. Proc R Soc Lond B Biol Sci 220: 141-162.
4. Black JW, Leff P, Shankley NP, Wood J (1985) An operational model of pharmacological agonism: the effect of E/[A] curve shape on agonist dissociation constant estimation. Br J Pharmacol 84: 561-571.
5. Bostrom E, Simonsson U, Hammarlund-Udenaes M (2006) In vivo blood-brain barrier transport of oxycodone in the rat: indications for active influx and implications for pharmacokinetics/pharmacodynamics. Drug Metab Dispos 34: 1624-1631.
6. Bouw MR, Gardmark M, Hammarlund-Udenaes M (2000) Pharmacokinetic- pharmacodynamic modelling of morphine transport across the blood-brain barrier as a cause of the antinociceptive effect delay in rats-a microdialysis study. Pharm Res 17: 1220-1227.
7. Bowser MT, Kennedy RT (2001) In vivo monitoring of amine neurotransmitters using microdialysis with on-line capillary electrophoresis. Electrophoresis 22: 3668-3676.
8. Brodie MS, Lee K, Fredholm BB, Stahle L, Dunwiddie TV (1987) Central versus peripheral mediation of responses to adenosine receptor agonists : evidence against a central mode of action. Brain Res 415: 323-330.
9. Brunner M, Hollenstein U, Detacher S, Jager D, Schmid R, Lackner E, Georgopoulos A, Eichler HG, Muller M (1999) Distribution and antimicrobial activity of ciprofloxacin in human soft tissues, Antimicrob Agents Chemother 43: 1307-1309.
10. Brunner M, Langer O (2006) Microdialysis versus other techniques for the clinical assessment of in vivo tissue drug distribution. AAPS J 8: 263-271.
11. Bundgaard C, Jorgensen M, Mork A (2007) An integrated microdialysis rat model for multiple pharmacokinetic/pharmacodynamic investigations of serotonergic agents. J Pharmacol Toxicol Methods 55: 214-223.
12. Bush MA, Pollack GM (2001) Pharmacokinetics and pharmacodynamics of 7-nitroindazole, a selective nitric oxide synthase inhibitor, in the rat hippocampus. Pharm Res 18: 1607-1612.
13. Chenel M, Marchand S, Dupuis A, Lamarche I, Paquereau J, Pariat C, Couet W (2004) Simultaneous central nervous system distribution and pharmacokinetic-pharmacodynamic modelling of the electroencephalogram effect of norfloxacin administered at a convulsant dose in rats. Br J Pharmacol 142: 323-330.
14. Christ GJ (1990) Determination of agonist dissociation constants in isolated vasculature: equivalence of estimates obtained by the method of partial irreversible receptor inactivation and a novel application of the operational model of pharmacological agonism. Life Sci 47: 1867-1874.
15. Chu J, Gallo JM (2000) Application of microdialysis to characterize drug disposition in tumors. Adv Drug Deliv Rev 45: 243-253.
16. Clinckers R, Smolders I, Meurs A, Ebinger G, Michotte Y (2005) Quantitative in vivo microdialysis study on the influence of multidrug transporters on the blood-brain barrier passage of oxcarbazepine: concomitant use of hippocampal monoamines as pharmacodynamic markers for the anticonvulsant activity. J Pharmacol Exp Ther 314: 725-731.
17. Craig WA (1998) Pharmacokinetic/pharmacodynamic parameters: rationale for antibacterial dosing of mice and men. Clin Infect Dis 26: 1-10.
18. Danhof M, Mandema JW, Hoogerkamp A, Mathot RAA (1993) Pharmacokinetic-pharmacodynamic modelling in pre-clinical investigations: principles and perspectives. Eur J Drug Metab Pharmacokinet 18: 41-47.
19. Day JC, Kornecook TJ, Quirion R (2001) Application of in vivo microdialysis to the study of cholinergic systems. Methods 23: 21-39.
20. de Lange EC, Danhof M, de Boer AG, Breimer DD (1997) Methodological considerations of intracerebral microdialysis in pharmacokinetic studies on drug transport across the blood-brain barrier. Brain Res Brain Res Rev 25: 27-49.
21. de Lange EC, de Boer AG, Breimer DD (2000) Methodological issues in microdialysis sampling for pharmacokinetic studies. Adv Drug Deliv Rev 45: 125-148.
22. de Lange EC, de Lange EC, Ravenstijn PG, Groenendaal D, van Steeg TJ (2005) Toward the prediction of CNS drug-effect profiles in physiological and pathological conditions using microdialysis and mechanism-based pharmacokinetic-pharmacodynamic modeling. AAPS J 7: 532-543.
23. Delacher S, Derendorf H, Hollenstein U, Brunner M, Joukhadar C, Hofmann S, Georgopoulos A, Eichler HG, Muller M (2000) A combined in vivo pharmacokinetic-in vitro pharmacodynamic approach to simulate target site pharmacodynamics of antibiotics in humans. J Antimicrob Chemother 46: 733-739.
24. Derendorf H, Meibohm B (1999) Modelling of pharmacokinetic/ pharmacodynamic (PK/PD) relationships: concepts and perspectives. Pharm Res 16: 176-185.
25. Derendorf H, Lesko JL, Chaikin P, Colbum WA, Lee P, Miller R, Powell R, Rhodes G, Stanski D, Venitz J (2000) Pharmacokinetic/pharmacodynamic modeling in drug research and development. J Clin Pharmacol 40: 1399-1418.
26. Dietz M, Harder S, Graff J, Kunig G, Vontobel P, Leenders KL, Baas H (2001) Levodopa pharmacokinetic-pharmacodynamic modeling and 6-[18F]levodopa positron emission tomography in patients with Parkinson's disease. Clin Pharmacol Ther 70: 33-41.
27. Duvvuri S, Rittenhouse KD, Mitra AK (2005) Microdialysis assessment of drug delivery systems for vitreoretinal targets. Adv Drug Deliv Rev 57: 2080-2091.
28. Elmquist WF, Sawchuk RJ (1997) Application of microdialysis in pharmacokinetic studies. Pharm Res 14: 267-287.
29. Ezzine S, Varin F (2005) Interstitial muscle concentrations of rocuronium under steady-state conditions in anaesthetized dogs: Actual versus predicted values. Br J Anaesth 94: 49-56.
30. Feng MR, Turluck D, Burleigh J, Lister R, Fan C, Middlebrook A, Taylor C, Su T (2001) Brain microdialysis and PK/PD correlation of pregabalin in rats. Eur J Drug Metab Pharmacokinet 26: 123-128.
31. Furchgott RF (1966) The use of b-haloalkylamines in the differentiation of receptors and in the determination of dissociation constants of receptor-agonist complexes. Adv Drug Res 3: 21-55.
32. Gomeni R, Bani M, D'Angeli C, Corsi M, Bye A (2001) Computer-assisted drug development (CADD): an emerging technology for designing first-time-in-man and proof-of-concept studies from preclinical experiments. Eur J Pharm Sci 13: 261-270.
33. Gunaratna PC, Kissinger PT, Kissinger CB, Gitzen JF (2004) An automated blood sampler for simultaneous sampling of systemic blood and brain microdialysates for drug absorption, distribution, metabolism, and elimination studies. J Pharmacol Toxicol Methods 49: 57-64.
34. Heinzen EL, Pollack GM (2003) Pharmacokinetics and pharmacodynamics of L-arginine in rats: a model of stimulated neuronal nitric oxide synthesis. Brain Res 989: 67-75.
35. Heppert KE, Davies MI (1999) Simultaneous determination of caffeine from blood, brain and muscle using microdialysis in an awake rat and the effect of caffeine on rat activity. Curr Separations 18: 3-7.
36. Hocht C, Opezzo JA, Gorzalczany SB, Priano RM, Bramuglia GF, Taira CA (2001) Pharmacokinetic and pharmacodynamic alterations of methyldopa in rats with aortic coarctation. A study using microdialysis. Pharmacol Res 44: 377-383.
37. Hocht C, Di Verniero C, Opezzo JA, Taira CA (2004) Pharmacokinetic- pharmacodynamic properties of metoprolol in chronic aortic coarctated rats. Naunyn Schmiedebergs Arch Pharmacol 370: 1-8.
38. Hocht C, Di Verniero C, Opezzo JA, Bramuglia GF, Taira CA (2006) Pharmacokinetic-pharmacodynamic (PK-PD) modeling of cardiovascular effects of metoprolol in spontaneously hypertensive rats: a microdialysis study. Naunyn Schmiedebergs Arch Pharmacol 373: 310-318.
39. Hows ME, Lacroix L, Heidbreder C, Organ AJ, Shah AJ (2004) High-performance liquid chromatography/tandem mass spectrometric assay for the simultaneous measurement of dopamine, norepinephrine, 5-hydroxytryptamine and cocaine in biological samples. J Neurosci Methods 138: 123-132.
40. Huff, JK, Davies MI (2002) Microdialysis monitoring of methylphenidate in blood and brain correlated with changes in dopamine and rat activity. J Biomed Pharm Anal 26: 767-777.
41. Hurd YL, Kehr J, Ungerstedt U (1988) In vivo microdialysis as a technique to monitor drug transport: correlation of extracellular cocaine levels and dopamine overflow in the rat brain. J Neurochem 51: 1314-1316.
42. Huynh BH, Fogarty BA, Martin RS, Lunte SM (2004) On-line coupling of microdialysis sampling with microchip-based capillary electrophoresis. Anal Chem 76: 6440-6447.
43. Joukhadar C, Dehghanyar P, Traunmuller F, Sauermann R, Mayer-Helm B, Georgopoulos A, Muller M (2005) Increase of microcirculatory blood flow enhances penetration of ciprofloxacin into soft tissue. Antimicrob Agents Chemother 49: 4149-4153.
44. Kanamori K, Kondrat RW, Ross BD (2003) 13C enrichment of extracellular neurotransmitter glutamate in rat brain: combined mass spectrometry and NMR studies of neurotransmitter turnover and uptake into glia in vivo. Cell Mol Biol (Noisy-le-grand) 49: 819-836.
45. Kanamori K, Ross BD (2005) Suppression of glial glutamine release to the extracellular fluid studied in vivo by NMR and microdialysis in hyperammonemic rat brain. J Neurochem 94: 74-85.
46. Kaptein WA, Zwaagstra JJ, Venema K, Korf J (1998) Continuous ultraslow microdialysis and ultrafiltration for subcutaneous sampling as demonstrated by glucose and lactate measurements in rats. Anal Chem 70: 4696-4700.
47. Larsson CI (1991) The use of an "internal standard" for control of the recovery in microdialysis. Life Sci 49: 73-78.
48. Latz JE, Rusthoven JJ, Karlsson MO, Ghosh A, Johnson RD (2006) Clinical application of a semimechanistic-physiologic population PK/PD model for neutropenia following pemetrexed therapy. Cancer Chemother Pharmacol 57: 427-435.
49. Li F, Feng J, Cheng Q, Zhu W, Jin Y (2007) Delivery of 1251-cobrotoxin after intranasal administration to the brain: a microdialysis study in freely moving rats. Int J Pharm 328: 161-167.
50. Lindon JC, Nicholson JK, Wilson ID (2000) Directly coupled HPLC-NMR and HPLC-NMR-MS in pharmaceutical research and development. J Chromatogr B Biomed Sci Appl 748: 233-258.
51. Lindon JC (2003) HPLC-NMR-MS: past, present and future. Drug Discov Today 8: 1021-1022.
52. Liu P, Muller M, Derendorf H (2002a) Rational dosing of antibiotics: the use of plasma concentrations versus tissue concentrations. Int J Antimicrob Agents 19: 285-290.
53. Liu P, Muller M, Grant M, Webb AI, Obermann B, Derendorf H (2002b) Interstitial tissue concentrations of cefpodoxime. J Antimicrob Chemother 50: 19-22.
54. Lommen A, Godejohann M, Venema DP, Hollman PC, Spraul M (2000) Application of directly coupled HPLC-NMR-MS to the identification and confirmation of quercetin glycosides and phloretin glycosides in apple peel. Anal Chem 72: 1793-1797.
55. Lucas LH, Wilson SF, Lunte CE, Larive CK (2005) Concentration profiling in rat tissue by high-resolution magic-angle spinning NMR spectroscopy: investigation of a model drug. Anal Chem 77: 2978-2984.
56. Malizia AL, Gunn RN, Wilson SJ, Waters SH, Bloomfield PM, Cunningham VJ, Nutt DJ (1996) Benzodiazepine site pharmacokinetic/pharmacodynamic quantification in man: direct measurement of drug occupancy and effects on the human brain in vivo. Neuropharmacology 35: 1483-1491.
57. Mayer BX, Namiranian K, Dehghanyar P, Stroh R, Mascher H, Muller M (2003) Comparison of UV and tandem mass spectrometric detection for the high-performance liquid chromatographic determination of diclofenac in microdialysis samples. J Pharm Biomed Anal 33: 745-754 .
58. McKim JM Jr, McKim JM Sr, Naumann S, Hammermeister DE, Hoffman AD, Klaassen CD (1993) In vivo microdialysis sampling of phenol and phenyl glucuronide in the blood of unanesthetized rainbow trout: implications for toxicokinetic studies. Fundam Appl Toxicol 20: 190-198.
59. Muller M (2000) Microdialysis in clinical drug delivery studies. Adv Drug Deliv Rev 45: 255-269.
60. Muller M (2002) Science, medicine, and the future: microdialysis. BMJ 324: 588-591.
61. Muller M, Mader RM, Steiner B, Steger GG, Jansen B, Gnant M, Helbich T, Jakesz R, Eichler HG, Blochl-Daum B (1997) 5-Fluorouracil kinetics in the interstitial tumor space: clinical response in breast cancer patients. Cancer Res 57: 2598-2601.
62. Muller M, Brunner M, Schmid R, Mader RM, Bockenheimer J, Steger GG, Steiner B, Eichler HG, Blochl-Daum B (1998) Interstitial methotrexate kinetics in primary breast cancer lesions. Cancer Res 58: 2982-2985.
63. Muller M, Brunner M, Schmid R, Putz EM, Schmiedberger A, Wallner I, Eichler HG (1998) Comparison of three different experimental methods for the assessment of peripheral compartment pharmacokinetics in humans. Life Sci 62: 227-234.
64. Muller M, Bockenheimer J, Zellenberg U, Klein N, Steger GG, Eichler HG, Mader RM (2000) Relationship between in vivo drug exposure of the tumor interstitium and inhibition of tumor cell growth in vitro: a study in breast cancer patients. Breast Cancer Res Treat 60: 211-217.
65. Nolting A, Dalla Costa T, Rand KH, Derendorf H (1996) Pharmacokinetic-pharmacodynamic modeling of the antibiotic effect of piperacillin in vitro. Pharm Res 13: 91-96.
66. Nomoto M (1995) Application of the common marmoset to pharmacological studies. Nippon Yakurigaku Zasshi 106: 11-18.
67. Nugroho AK, Romeijn SG, Zwier R, de Vries JB, Dijkstra D, Wikstrom H, Della-Pasqua O, Danhof M, Bouwstra JA (2006) Pharmacokinetics and pharmacodynamics analysis of transdermal iontophoresis of 5-OH-DPAT in rats: in vitro-in vivo correlation. J Pharm Sci 95: 1570-1585.
68. Opezzo JA, Hocht C, Taira CA, Bramuglia GF (2000) Study of the evolution of blood and striatal levels of methyldopa: A microdialysis study in sinaortic denervated rat. Pharm Res 41: 455-459.
69. Osborne PG (1995) Fixed versus removable microdialysis probes for in vivo neurochemical analysis: implications for behavioral studies. J Neurochem 64: 1899-1901.
70. Plock N, Kloft C (2005) Microdialysis-theoretical background and recent implementation in applied life-sciences. Eur J Pharm Sci 25: 1-24.
71. Rabenstein K, McShane AJ, McKenna MJ, Dempsey E, Keaveny TV, Freaney R (1996) An intravenous microdialysis sampling system suitable for application in continuos monitoring of glucose and lactate. Technol Health Care 4: 67-76.
72. Raje S, Cornish J, Newman AH, Cao J, Katz JL, Eddington ND (2005) Pharmacodynamic assessment of the benztropine analogues AHN-1055 and AHN-2005 using intracerebral microdialysis to evaluate brain dopamine levels and pharmacokinetic/pharmacodynamic modeling. Pharm Res 22: 603-612.
73. Schaupp L, Ellmerer M, Brunner GA, Wutte A, Sendlhofer G, Trajanoski Z, Skrabal F, Pieber TR, Wach P (1999) Direct access to interstitial fluid in adipose tissue in humans by use of open-flow microperfusion. Am J Physiol 276: 401-408.
74. Seddon BM, Workman P (2003) The role of functional and molecular imaging in cancer drug discovery and development. Br J Radiol 76: 128-138.
75. Shichiri M, Sakakida M, Nishida K, Araki E (2002) Contribution of Japanese researchers to the progress of studies in endocrinology and metabolism in the field of internal medicine in the last 100 years: Artificial endocrine pancreas. Nippon Naika Gakkai Zasshi 91: 1137-1139.
76. Shimura T, Suzuki M, Yamamoto T (1995) Aversive taste stimuli facilitate extracellular acetylcholine release in the insular gustatory cortex of the rat: a microdialysis study. Brain Res 679: 221-226.
77. Touchet N, Bennett JP Jr. (1989) The metabolism of systemically- administered L-dihydroxy-phenylalanine, by intact and dopamine-denervated striata, as revealed by brain microdialysis. Neuropharmacology 28: 1217-1222.
78. Toutain PL (2002) Pharmacokinetic/Pharmacodynamic integration in drug development and dosage-regimen optimization for veterinary medicine. AAPS PharmSci 4: 38.
79. Ungerstedt U, Pycock C (1974) Functional correlates of dopamine neurotransmission. Bull Schweiz Akad Med Wiss 30: 44-55.
80. Van Belle K, Dzeka T, Sarre S, Ebinger G, Michotte Y (1993) In vitro and in vivo microdialysis calibration for the measurement of carbamazepine and its metabolites in rat brain tissue using the internal reference technique. J Neurosci Methods 49: 167-173.
81. Van der Graaf PH, Danhof M (1997) Analysis of drug-receptor interactions in vivo: a new approach in pharmacokinetic-pharmacodynamic modelling. Int J Clin Pharmacol Ther 35: 442-446.
82. Van der Graaf PH, Van Schaick EA, Visser SA, De Greef HJ, Ijzerman AP, Danhof M (1999) Mechanism-based pharmacokinetic/pharmacodynamic modeling of antilipolytic effects of adenosine A1 receptor agonists in rats: prediction of tissue-dependent efficacy in vivo. J Pharmacol Exp Ther 290: 702-709.
83. Weikop P, Egestad B, Kehr J (2004) Application of triple-probe microdialysis for fast pharmacokinetic/pharmacodynamic evaluation of dopamimetic activity of drug candidates in the rat brain. J Neurosci Methods 140: 59-65.
84. Workman P, Aboagye EO, Chung YL, Griffiths JR, Hart R, Leach MO, Maxwell RJ, McSheehy PM, Price PM, Zweit J (2006) Minimally invasive pharmacokinetic and pharmacodynamic technologies in hypothesis-testing clinical trials of innovative therapies. J Natl Cancer Inst 98: 580-598.
85. Yokel RA, Allen DD, Burgio DE, McNamara PJ (1992) Antipyrine as a dialyzable reference to correct differences in efficiency among and within sampling devices during in vivo microdialysis. J Pharmacol Toxicol Methods 27: 135-142.
86. Zhou Q, Gallo JM (2005) In vivo microdialysis for PK and PD studies of anticancer drugs. AAPS J 7: 659-667.
87. Zhou Q, Guo P, Wang X, Nuthalapati S, Gallo JM (2007) Preclinical pharmacokinetic and pharmacodynamic evaluation of metronomic and conventional temozolomide Dosing Regimens. J Pharmacol Exp Ther. 321: 265-275.